Center-Authored Papers

Filters: Author is Shadman, Mazyar  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Balkin ER, Kenoyer A, Orozco JJ, Hernandez A, Shadman M, Fisher DR, Green DJ, Hylarides MD, Press OW, Wilbur SD et al..  2014.  In vivo localization of 90Y and 177Lu radioimmunoconjugates using Cerenkov luminescence imaging in a disseminated murine leukemia model.. Cancer research. 74(20):5846-54. Abstract
Burnett-Hartman AN, Newcomb PA, Mandelson MT, Adams SV, Wernli KJ, Shadman M, Wurscher MA, Makar KW.  2011.  Colorectal polyp type and the association with charred meat consumption, smoking, and microsomal epoxide hydrolase polymorphisms.. Nutrition and cancer. 63(4):583-92. Abstract
C
Chauncey TR, Gundacker H, Shadman M, List AF, Dakhil SR, Erba HP, Slovak ML, Chen I-M, Willman CL, Kopecky KJ et al..  2010.  Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia.. British journal of haematology. 148(1):48-58. Abstract
Cowan AJ, Stevenson PA, Cassaday RD, Graf SA, Fromm JR, Wu D, Holmberg LA, Till BG, Chauncey TR, Smith SD et al..  2015.  Pretransplant minimal residual disease predicts survival in mantle cell lymphoma patients undergoing autologous stem cell transplantation in complete remission.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
G
Green DJ, Shadman M, Jones JC, Frayo SL, Kenoyer AL, Hylarides MD, Hamlin DK, Wilbur SD, Balkan ER, Lin Y et al..  2015.  Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model.. Blood. 125(13):2111-9. Abstract
H
Hay KA, Gauthier J, Hirayama AV, Voutsinas JM, Wu Q, Li D, Gooley TA, Cherian S, Chen X, Pender BS et al..  2019.  Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy.. Blood. 133(15):1652-1663. Abstract
L
Lionberger JM, Pagel JM, Sandhu VK, Xie H, Shadman M, Mawad R, Boehm A, Dean C, Shannon-Dorcy K, Scott BL et al..  2014.  Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statistical design.. British journal of haematology. 166(3):375-81. Abstract
O
O'Brien KL, Pereira SE, Wagner J, Shadman M, Hendrie P, Nelson K, Gernsheimer TB, Price T, Reyes JD, Nester T.  2013.  Transfusion-associated graft-versus-host disease in a liver transplant recipient: an unusual presentation and review of the literature.. Transfusion. 53(1):174-80. Abstract
Orozco JJ, Balkin ER, Gooley TA, Kenoyer A, Hamlin DK, Wilbur SD, Fisher DR, Hylarides MD, Shadman M, Green DJ et al..  2014.  Anti-CD45 radioimmunotherapy with 90Y but not 177Lu is effective treatment in a syngeneic murine leukemia model.. PloS one. 9(12):e113601. Abstract
R
Reddy P, Kanan S, Cowan A, Warren H, Till B, Shadman M, Cassaday R, Press O, Shustov A, Gopal A et al..  2017.  Pegylated GCSF Can Be Used With First-Line da-EPOCH-R Without Compromising Dose Intensity, Safety, or Efficacy.. Clinical lymphoma, myeloma & leukemia. Abstract
S
Shadman M, Gopal AK, Kammerer B, Becker PS, Maloney DG, Pender B, Shustov AR, Press OW, Pagel JM.  2015.  Radioimmunotherapy Consolidation using (131)I-Tositumomab for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in First Remission.. Leukemia & lymphoma. 57(3):572-6. Abstract
Shadman M, Estey EH.  2013.  Prophylactic use of granulocyte colony-stimulating factor after consolidation therapy with high-dose cytarabine for acute myeloid leukemia.. Expert review of hematology. 6(2):131-3. Abstract
Shadman M, Mawad R, Dean C, Chen TL, Shannon-Dorcy K, Sandhu V, Hendrie PC, Scott BL, Walter RB, Becker PS et al..  2015.  Idarubicin, cytarabine, and pravastatin as induction therapy for untreated acute myeloid leukemia and high-risk myelodysplastic syndrome.. American journal of hematology. 90(6):483-6. Abstract
Shadman M, Hingorani S, Lanum SA, Pagel JM, Storb R, Maloney DG, Sandmaier BM.  2016.  Allogeneic hematopoietic cell transplant for patients with end stage renal disease requiring dialysis - a single institution experience.. Leukemia & lymphoma. :1-3.
Shadman M, White E, De Roos AJ, Walter RB.  2013.  Associations between allergies and risk of hematologic malignancies:Results from the VITamins and lifestyle (VITAL) cohort study.. American journal of hematology. 88(12):1050-4. Abstract
Shadman M, Newcomb PA, Hampton JM, Wernli KJ, Trentham-Dietz A.  2009.  Non-steroidal anti-inflammatory drugs and statins in relation to colorectal cancer risk.. World journal of gastroenterology : WJG. 15(19):2336-9. Abstract
W
Wernli KJ, Newcomb PA, Wang Y, Makar KW, Shadman M, Chia VM, Burnett-Hartman A, Wurscher MA, Zheng Y, Mandelson MT.  2010.  Body size, IGF and growth hormone polymorphisms, and colorectal adenomas and hyperplastic polyps.. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society. 20(4):305-9. Abstract
Winter AM, Landsburg DJ, Mato AR, Isaac K, Hernandez-Ilizaliturri FJ, Reddy N, Smith S, Shadman M, Smith MR, Caimi P et al..  2017.  A multi-institutional outcomes analysis of patients with relapsed or refractory DLBCL treated with ibrutinib.. Blood.